Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/112220
DC FieldValueLanguage
dc.contributor.authorGao, Rui-
dc.contributor.authorAcreman, Samuel-
dc.contributor.authorMa, Jinfang-
dc.contributor.authorAbdulkader, Fernando-
dc.contributor.authorWendt, Anna-
dc.contributor.authorZhang, Quan-
dc.date.accessioned2024-01-25T11:04:31Z-
dc.date.available2024-01-25T11:04:31Z-
dc.date.issued2023-08-01-
dc.identifier.issn0022-0795pt
dc.identifier.issn1479-6805pt
dc.identifier.urihttps://hdl.handle.net/10316/112220-
dc.description.abstractGlucagon is the principal glucose-elevating hormone that forms the first-line defence against hypoglycaemia. Along with insulin, glucagon also plays a key role in maintaining systemic glucose homeostasis. The cells that secrete glucagon, pancreatic α-cells, are electrically excitable cells and use electrical activity to couple its hormone secretion to changes in ambient glucose levels. Exactly how glucose regulates α-cells has been a topic of debate for decades but it is clear that electrical signals generated by the cells play an important role in glucagon secretory response. Decades of studies have already revealed the key players involved in the generation of these electrical signals and possible mechanisms controlling them to tune glucagon release. This has offered the opportunity to fully understand the enigmatic α-cell physiology. In this review, we describe the current knowledge on cellular electrophysiology and factors regulating excitability, glucose sensing, and glucagon secretion. We also discuss α-cell pathophysiology and the perspective of addressing glucagon secretory defects in diabetes for developing better diabetes treatment, which bears the hope of eliminating hypoglycaemia as a clinical problem in diabetes care.pt
dc.language.isoengpt
dc.publisherBioScientifica Ltd.pt
dc.relationThis work has been supported by a Diabetes UK RD Lawrence Fellowship (14/0005128) (QZ) and an EFSD New Targets for Diabetes or Obesityrelated Metabolic Diseases Programme (QZ), the Swedish Foundation for Strategic Research (IRC-LUDC; AW), the Swedish Research Council (SFOEXODIAB; AW), the Albert Påhlsson Foundation (AW), and National Natural Science Foundation of China (82200887) (RG).pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectα-cellpt
dc.subjectelectrophysiologypt
dc.subjectglucagonpt
dc.subjectdiabetespt
dc.subject.meshHumanspt
dc.subject.meshGlucagonpt
dc.subject.meshInsulinpt
dc.subject.meshGlucosept
dc.subject.meshCell Physiological Phenomenapt
dc.subject.meshElectrophysiologypt
dc.subject.meshGlucagon-Secreting Cellspt
dc.subject.meshDiabetes Mellituspt
dc.subject.meshHypoglycemiapt
dc.titleα-cell electrophysiology and the regulation of glucagon secretionpt
dc.typearticle-
degois.publication.issue2pt
degois.publication.titleThe Journal of endocrinologypt
dc.peerreviewedyespt
dc.identifier.doi10.1530/JOE-22-0295pt
degois.publication.volume258pt
dc.date.embargo2023-08-01*
uc.date.periodoEmbargo0pt
item.openairetypearticle-
item.fulltextCom Texto completo-
item.languageiso639-1en-
item.grantfulltextopen-
item.cerifentitytypePublications-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
crisitem.author.researchunitCNC - Center for Neuroscience and Cell Biology-
crisitem.author.orcid0000-0002-3626-4855-
Appears in Collections:I&D CNC - Artigos em Revistas Internacionais
Show simple item record

Page view(s)

23
checked on Jul 17, 2024

Download(s)

7
checked on Jul 17, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons